Literature DB >> 11855812

MUC17, a novel membrane-tethered mucin.

James R Gum1, Suzanne C Crawley, James W Hicks, David E Szymkowski, Young S Kim.   

Abstract

Membrane mucins have several functions in epithelial cells including cytoprotection, extravasation during metastases, maintenance of luminal structure, and signal transduction. In this paper we describe a large membrane mucin expressed in the normal intestine. This novel mucin, designated MUC17, contains an extended, repetitive extracellular glycosylation domain and a carboxyl terminus with two EGF-like domains, a SEA module domain, a transmembrane domain, and a cytoplasmic domain with potential serine and tyrosine phosphorylation sites. RNA blot analysis and in situ hybridization indicates that MUC17 is expressed in select pancreatic and colon cancer cell lines and in intestinal absorptive cells. Radiation hybrid mapping localized MUC17 to chromosome 7q22 where it resides in close proximity with three other membrane mucin genes, MUC3A, MUC3B, and MUC12. Thus, these membrane mucins reside together in a gene cluster, but are expressed in different tissues and are likely to have different functions as well.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11855812     DOI: 10.1006/bbrc.2002.6475

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  68 in total

1.  DNA methylation and histone H3-K9 modifications contribute to MUC17 expression.

Authors:  Sho Kitamoto; Norishige Yamada; Seiya Yokoyama; Izumi Houjou; Michiyo Higashi; Masamichi Goto; Surinder K Batra; Suguru Yonezawa
Journal:  Glycobiology       Date:  2010-10-06       Impact factor: 4.313

Review 2.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

Review 3.  Giant intrahepatic biliary cystadenoma in a male: a case report, immunohistopathological analysis, and review of the literature.

Authors:  Shinsuke Kazama; Takeyuki Hiramatsu; Shigeru Kuriyama; Ken Kuriki; Ryo Kobayashi; Naoki Takabayashi; Kenichi Furukawa; Masami Kosukegawa; Hitoshi Nakajima; Kousuke Hara
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

Review 4.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 5.  Mucin overproduction in chronic inflammatory lung disease.

Authors:  Hans-Peter Hauber; Susan C Foley; Qutayba Hamid
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

Review 6.  Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer.

Authors:  Ajay P Singh; Shantibhusan Senapati; Moorthy P Ponnusamy; Maneesh Jain; Subodh M Lele; John S Davis; Steven Remmenga; Surinder K Batra
Journal:  Lancet Oncol       Date:  2008-11       Impact factor: 41.316

Review 7.  Membrane mucins of the intestine at a glance.

Authors:  Thaher Pelaseyed; Gunnar C Hansson
Journal:  J Cell Sci       Date:  2020-03-13       Impact factor: 5.285

Review 8.  Current status of mucins in the diagnosis and therapy of cancer.

Authors:  Satyanarayana Rachagani; Maria P Torres; Nicolas Moniaux; Surinder K Batra
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

9.  Mucin dynamics in intestinal bacterial infection.

Authors:  Sara K Lindén; Timothy H J Florin; Michael A McGuckin
Journal:  PLoS One       Date:  2008-12-17       Impact factor: 3.240

10.  Mucins in ovarian cancer diagnosis and therapy.

Authors:  Subhash C Chauhan; Deepak Kumar; Meena Jaggi
Journal:  J Ovarian Res       Date:  2009-12-24       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.